Outbreak Control Rapid Response Service

Minimise Organisational Disruption during a COVID-19 outbreak with MediClean UK 4-step Rapid Response Service



1. Identify and isolate members


As per government test and trace protocol isolate those with positive test results and their close contacts.


“A 'contact' is a person who has been close to someone who has tested positive for coronavirus (COVID-19) anytime from 2 days before the person was symptomatic up to 7 days from onset of symptoms (this is when they are infectious to others).”


2. Top to bottom site disinfection sweep using Mediclean UK


Professionally trained technicians. All surfaces are treated with Medi-Shield solution, EN14476 certified to kill envelope viruses. For quick acting non toxic disinfection that can be applied to all surfaces within the organisation.


3. Application of Medi-Shield Antimicrobial Protection


ISO 21702 certified shows a log reduction of 1.03 which is 91.09% effective against envelope viruses after the solution has been applied and has dried onto the surface. Designed to prevent further spread of the virus around your facility in the event of an infected individual being reintroduced or contaminated areas 're-seeding' the cross-infection process.


4. Rapid Covid-19 Antigen test 


Quick COVID-19 rapid tests detect either the body’s response to coronavirus or identify the virus antigen itself and give qualitative yes/no results within 15 minutes.


Our tests are currently used within the NHS and provide reassurance that your temporary team is good to go reducing the risk of repeat outbreaks during the 14-day quarantine period.


Our Covid-19 rapid tests will identify the virus up to 3 days before symptoms develop.

Rapid test system for novel COVID-19 cor

About Our COVID-19 Antigen Test Cassette

Our COVID-19 rapid test identifies COVID-19 present in a swab sample and gives a qualitative yes/no result within 15 minutes.

The test is perfect for screening quickly at the patient side for the presence of COVID-19. 

Implementing rapid screening for COVID-19 has huge time and cost savings when compared to, or integrated into, laboratory screening, and will help to control the spread of the virus by identifying active infection rapidly and accurately.

A swab is used to sample from either the nose or throat (nasopharyngeal or oropharyngeal sample) and introduced into the test cassette by suspension in a buffer solution.